Targeted Mesoporous Silica Nanoparticles Delivering Arsenic Trioxide with Environment Sensitive Drug Release for Effective Treatment of Triple Negative Breast Cancer

ACS Biomaterials Science and Engineering

Volumn 2, Issue 4, 2016, Pages 501-507

  Wu, Xiaohui ^a   Han, Zheng ^a   Schur, Rebecca M ^a   Lu, Zheng Rong ^a  

^a Case Western Reserve University   (United States)

Author keywords

arsenic trioxide; breast cancer; nanoparticles; targeting

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; ARSENIC TRIOXIDE; GLUTATHIONE; MESOPOROUS SILICA NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TARGETING; DRUG UPTAKE; ENCAPSULATION; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE AREA; SURFACE PROPERTY; THERMOGRAVIMETRY; TRANSMISSION ELECTRON MICROSCOPY; TRIPLE NEGATIVE BREAST CANCER; X RAY DIFFRACTION;

EID: 84969277665     PISSN: None     EISSN: 23739878     Source Type: Journal    
DOI: 10.1021/acsbiomaterials.5b00398     Document Type: Article

References (33)

1. Cho, K. J.; Wang, X.; Nie, S. M.; Chen, Z.; Shin, D. M. Therapeutic nanoparticles for drug delivery in cancer Clin. Cancer Res. 2008, 14, 1310-1316 10.1158/1078-0432.CCR-07-1441
2. Lu, J.; Liong, M.; Li, Z.; Zink, J. I.; Tamanoi, F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals Small 2010, 6, 1794-1805 10.1002/smll.201000538
3. Wang, J.; Sui, M.; Fan, W. Nanoparticles for tumor targeted therapies and their pharmacokinetics Curr. Drug Metab. 2010, 11, 129-141 10.2174/138920010791110827
4. Ge, H. X.; Hu, Y.; Jiang, X. Q.; Cheng, D. M.; Yuan, Y. Y.; Bi, H.; Yang, C. Z. Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) amphiphilic triblock copolymer micelles J. Pharm. Sci. 2002, 91, 1463-1473 10.1002/jps.10143
5. Angst, M. S.; Drover, D. R. Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology Clin. Pharmacokinet. 2006, 45, 1153-1176 10.2165/00003088-200645120-00002
6. Byrne, J. D.; Betancourt, T.; Brannon-Peppas, L. Active targeting schemes for nanoparticle systems in cancer therapeutics Adv. Drug Delivery Rev. 2008, 60, 1615-1626 10.1016/j.addr.2008.08.005
7. Kukowska-Latallo, J. F.; Candido, K. A.; Cao, Z. Y.; Nigavekar, S. S.; Majoros, I. J.; Thomas, T. P.; Balogh, L. P.; Khan, M. K.; Baker, J. R. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer Cancer Res. 2005, 65, 5317-5324 10.1158/0008-5472.CAN-04-3921
8. Bellocq, N. C.; Pun, S. H.; Jensen, G. S.; Davis, M. E. Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery Bioconjugate Chem. 2003, 14, 1122-1132 10.1021/bc034125f
9. Flenniken, M. L.; Liepold, L. O.; Crowley, B. E.; Willits, D. A.; Young, M. J.; Douglas, T. Selective attachment and release of a chemotherapeutic agent from the interior of a protein cage architecture Chem. Commun. 2005, 447-449 10.1039/b413435d
10. Shi Kam, N. W; O'Connell, M.; Wisdom, J. A.; Dai, H. J. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 11600-11605 10.1073/pnas.0502680102
11. Swindell, E. P.; Hankins, P. L.; Chen, H.; Miodragovic, D. U.; O'Halloran, T. V. Anticancer activity of small-molecule and nanoparticulate arsenic(III) complexes Inorg. Chem. 2013, 52, 12292-12304 10.1021/ic401211u
12. Haller, J. S. Therapeutic mule: the use of arsenic in the nineteenth century materia medica Pharm. Hist. 1975, 17, 87-100
13. Dilda, P. J.; Hogg, P. J. Arsenical-based cancer drugs Cancer Treat. Rev. 2007, 33, 542-564 10.1016/j.ctrv.2007.05.001
14. Ahn, R. W.; Chen, F.; Chen, H.; Stern, S. T.; Clogston, J. D.; Patri, A. K.; Raja, M. R.; Swindell, E. P.; Parimi, V.; Cryns, V. L.; O'Halloran, T. V. A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer Clin. Cancer Res. 2010, 16, 3607-3617 10.1158/1078-0432.CCR-10-0068
15. Zhao, Z.; Zhang, H.; Chi, X.; Li, H.; Yin, Z.; Huang, D.; Wang, X.; Gao, J. Silica nanovehicles endow arsenic trioxide with an ability to effectively treat cancer cells and solid tumors J. Mater. Chem. B 2014, 2, 6313-6323 10.1039/C4TB00874J
16. Zhao, Z.; Wang, X.; Zhang, Z.; Zhang, H.; Liu, H.; Zhu, X.; Li, H.; Chi, X.; Yin, Z.; Gao, J. Real-time monitoring of arsenic trioxide release and delivery by activatable T1 imaging ACS Nano 2015, 9, 2749-2759 10.1021/nn506640h
17. Zhang, L.; Zhang, Z.; Mason, R. P.; Sarkaria, J. N.; Zhao, D. Convertible MRI contrast: sensing the delivery and release of anti-glioma nano-drugs Sci. Rep. 2015, 5, 09874 10.1038/srep09874
18. Zhou, Z.; Wu, X.; Kresak, A.; Griswold, M.; Lu, Z.-R. Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI Biomaterials 2013, 34, 7683-7693 10.1016/j.biomaterials.2013.06.057
19. He, Q.; Zhang, J.; Shi, J.; Zhu, Z.; Zhang, L.; Bu, W.; Guo, L.; chen, Y. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses Biomaterials 2010, 31, 1085-1092 10.1016/j.biomaterials.2009.10.046
20. Lu, F.; Wu, S. H.; Hung, Y.; Mou, C. Y. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles Small 2009, 5, 1408-1413 10.1002/smll.200900005
21. Wardman, P.; Dennis, M. F.; Stratford, M. R.; White, J. Extracellular: intracellular and subcellular concentration gradients of thiols Int. J. Radiat. Oncol., Biol., Phys. 1992, 22, 751-754 10.1016/0360-3016(92)90517-L
22. Cheng, R.; Feng, F.; Meng, F.; Deng, C.; Feijen, J.; Zhong, Z. Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery J. Controlled Release 2011, 152, 2-12 10.1016/j.jconrel.2011.01.030
23. He, L.; Huang, Y.; Zhu, H.; Pang, G.; Zheng, W.; Wong, Y. S.; Chen, T. Cancer-targeted monodisperse mesoporous silica nanoparticles as carrier of ruthenium polypyridyl complexes to enhance theranostic effects Adv. Funct. Mater. 2014, 24, 2754-2763 10.1002/adfm.201303533
24. Ferris, D. P.; Lu, J.; Gothard, C.; Yanes, R.; Thomas, C. R.; Olsen, J. C.; Stoddart, J. F.; Tamanoi, F.; Zink, J. I. Synthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells Small 2011, 7, 1816-1826 10.1002/smll.201002300
25. Trewyn, B. G.; Nieweg, J. A.; Zhao, Y.; Lin, V. S. Y. Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane penetration Chem. Eng. J. 2008, 137, 23-29 10.1016/j.cej.2007.09.045
26. Lu, Z. R.; Kopeckova, P.; Kopecek, J. Polymerizable Fab' antibody fragments for targeting of anticancer drugs Nat. Biotechnol. 1999, 17, 1101-1104 10.1038/15085
27. Garanger, E.; Boturyn, D.; Dumy, P. Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers Anti-Cancer Agents Med. Chem. 2007, 7, 552-558 10.2174/187152007781668706
28. Danhier, F.; Vroman, B.; Lecouturier, N.; Crokart, N.; Pourcelle, V.; Freichels, H.; Jerome, C.; Marchand-Brynaert, J.; Feron, O.; Preat, V. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel J. Controlled Release 2009, 140, 166-173 10.1016/j.jconrel.2009.08.011
29. 3) in the orthotopic metastasis model of androgen-independent prostate cancer Cancer Res. 2001, 61, 5432-5440
30. Liu, B.; Pan, S.; Dong, X.; Qiao, H.; Jiang, H.; Krissansen, G. W.; Sun, X. Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice Cancer Sci. 2006, 97, 675-681 10.1111/j.1349-7006.2006.00230.x
31. Soucy, N. V.; Ihnat, M. A.; Kamat, C. D.; Hess, L.; Post, M. J.; Klei, L. R.; Clark, C.; Barchowsky, A. Arsenic stimulates angiogenesis and tumorigenesis in vivo Toxicol. Sci. 2003, 76, 271-279 10.1093/toxsci/kfg231
32. Beauchamp, E. M.; Ringer, L.; Bulut, G.; Sajwan, K. P.; Hall, M. D.; Lee, Y. C.; Peaceman, D.; Ozdemirli, M.; Rodriguez, O.; Macdonald, T. J.; Albanese, C.; Toretsky, J. A.; Uren, A. Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking hedgehog/GLI pathway J. Clin. Invest. 2011, 121, 148-160 10.1172/JCI42874
33. Evens, A. M.; Tallman, M. S.; Gartenhaus, R. B. The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future Leuk. Res. 2004, 28, 891-900 10.1016/j.leukres.2004.01.011